Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0714_s41467-020-17206-4

Retrotransposons as acute myelogenous leukemia targets

Aug 27, 2020 | 10:08 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Acute

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE